-transparent.png){kind=logo}
Developments leading to the preparation and testing for safety and potency of a highly purified inactivated preparation of hepatitis B surface antigen are descirbed. Protective efficacy studies in chimps of a lot of the inactivated hepatitis B vaccine are currently and suitable for clinical trials in man.
Related Publications
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
December 2007,
Expert review of vaccines,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
December 1973,
British medical journal,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
July 1999,
Vaccine,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
May 1984,
Connecticut medicine,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
August 1992,
Releve epidemiologique hebdomadaire,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
November 1999,
Alimentary pharmacology & therapeutics,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
January 1980,
Progress in clinical and biological research,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
May 2011,
Pharmaceutical research,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
November 2014,
The Journal of infectious diseases,
M R Hilleman, and
E B Buynak, and
R R Roehm, and
A A Tytell, and
A U Bertland, and
G P Lampson
December 2004,
The Southeast Asian journal of tropical medicine and public health,
